ERBB2 and breast cancer: Breast cancer is a heterogeneous disease and the PAM50 molecular subtypes of breast tumors, Luminal A, Luminal B, HER2-enriched, Basal-like, have distinct biological properties that can be used as markers for prognosis [16–20].